0001562180-19-000371.txt : 20190118
0001562180-19-000371.hdr.sgml : 20190118
20190118173731
ACCESSION NUMBER: 0001562180-19-000371
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190116
FILED AS OF DATE: 20190118
DATE AS OF CHANGE: 20190118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CARSCADDEN GWEN R.
CENTRAL INDEX KEY: 0001590948
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36545
FILM NUMBER: 19533920
MAIL ADDRESS:
STREET 1: C/O INTERSECT ENT, INC.
STREET 2: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intersect ENT, Inc.
CENTRAL INDEX KEY: 0001271214
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 200280837
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-641-2100
MAIL ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: SINEXUS INC
DATE OF NAME CHANGE: 20031124
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-01-16
false
0001271214
Intersect ENT, Inc.
XENT
0001590948
CARSCADDEN GWEN R.
C/O INTERSECT ENT, INC.
1555 ADAMS DRIVE
MENLO PARK
CA
94025
false
true
false
false
Chief People Officer
Common Stock
2019-01-16
4
A
false
4500.00
0.00
A
12179.00
D
Stock Option (right to buy)
28.58
2019-01-16
4
A
false
21000.00
0.00
A
2029-01-15
Common Stock
21000.00
21000.00
D
Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in three equal annual installments commencing on January 1, 2019.
Includes 9,533 Restricted Stock Units.
The vesting commencement date of the option is January 1, 2019. 1/8th of the shares subject to the option shall vest on July 1, 2019 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months.
David A. Lehman, Attorney-in-Fact for Gwen Carscadden
2019-01-18